Monday, February 11, 2008

Diabetes Trial Ends Dangerous Treatment

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue. Click on the blue title above to read more.

No comments: